编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
184191 | MDK-1699 | 432001-69-9 | >98% | |
MDK-1699,也称为Skp2抑制剂C1和SKPinC1,是一种Skp2抑制剂。 | ||||
184173 | MDK-6149 | 508186-14-9 | >98% | |
MDK-6149,也被称为ACSS2抑制剂或Ac-CoA合成酶抑制剂I,是一种Ac-CoA合 | ||||
184161 | MDK-7933 | 1417997-93-3 | >98% | |
MDK-7933,也称为HDAC8-IN-1,是一种HDAC8 抑制剂,在癌症细胞器的IC50 | ||||
184104 | MDK7526盐酸盐 | 1448189-80-7 | >98% | |
MDK7526, 也称为VHL Ligand 1,Protein degrader 1是一种有效的、选择性的蛋 | ||||
184103 | MRT68921 | 1190379-70-4 | >98% | |
MRT68921是ULK1和ULK2的抑制剂(IC50 分别为= 2.9和1.1 nM)。 | ||||
184102 | MRT68921盐酸盐 | 2080306-21-2 | >98% | |
MRT68921是ULK1和ULK2的抑制剂(IC50分别为 = 2.9和1.1 nM)。 | ||||
184219 | Mc-Val-Ala-PAB | 1870916-87-2 | >98% | |
Mc-Val-Ala-PAB 是一种用于靶向药物传递的药物-药物结合剂(ADC)的有用 | ||||
184216 | ML335 | 825658-06-8 | >98% | |
ML335 is a potent and selective TREK-1/2 Activator. ML335 is an agonist for OPRM1-OPR | ||||
184215 | ML365 | 947914-18-3 | >98% | |
ML365 is a potent and selective K2P3.1 TASK-1 channel blocker. | ||||
184211 | MDK7229 | 111797-22-9 | >98% | |
MDK7229, also known as MD2-IN-1 is a MD2 (Myeloid differentiation protein 2) inhibito | ||||
18422 | ML204 HCl | 2070015-10-8 | >98% | |
ML204 is a novel and potential TRPC4 Channel inhibitor.ML204 represents an excellent | ||||
18421 | MDK6574 | 2102196-57-4 | >98% | |
MDK6574,也称为FAA1 agonist-1,FAA1受体激动剂。 | ||||
183131 | 2-甲基-7-氮杂吲哚 | 23612-48-8 | >96% | |
2-甲基-7-氮杂吲哚是一种医药中间体。 | ||||
1712293 | 4-methylsulfonyl-2-(trifluoromethyl)benzaldehyde | 1215310-75-0 | >96% | |
4-methylsulfonyl-2-(trifluoromethyl)benzaldehyde isa building blocks. | ||||
1710163 | MK-8617 | 1187990-87-9 | >98% | |
MK-8617是一种缺氧诱导因子(HIF脯氨酰羟化酶1−3 PHD1−3),具有强效 | ||||
1710135 | MSC2530818 | 1883423-59-3 | >98% | |
MSC2530818是一种强效、选择性,口服生物利用度与抑制剂的IC50 = 2. | ||||
1791512 | MDK19922 | 132819-92-2 | 98.0% | |
MDK19922,也称为NOD-IN-1或化合物4,是一种有效的核苷酸结合寡聚化 | ||||
179154 | 游离莫扎伐普坦 | 137975-06-5 | 98.0% | |
莫扎伐普坦,又名OPC 31260,是由大冢销售的血管加压素受体拮抗剂 | ||||
179152 | ML-141 | 71203-35-5 | 98.0% | |
ML-141,也称为CID2950007,是Cdc42抑制剂(EC50 = 2.1μm)。 | ||||
179138 | MDK30165 | 2060530-16-5 | 98.0% | |
MDK30165,也称为K-Ras(G12C)抑制剂6。 | ||||
20179132 | 单甲基澳瑞他汀 D | 203849-91-6 | 98.0% | |
MMAD又称为单甲基澳瑞他汀 D,是一种高效的微管蛋白抑制剂。MMAD | ||||
179119 | ML-385 | 846557-71-9 | 98.0% | |
ML-385是强有力的和有选择性的Nrf2抑制剂(IC50 = 1.9μNrf2;M)。ML-3 | ||||
179115 | ML-277 | 516480-79-8 | 98.0% | |
ML-277,又名Chk2抑制剂II,是Chk2(检查点激酶2)抑制剂。ML-277凋亡 | ||||
179114 | MDK35833 | 1016535-83-3 | 98.0% | |
MDK35833又称为Oct3/4-inducer-1,是一种有效率的Oct3/4诱导者。MDK35833可 | ||||
179111 | ML241 HCl | 2070015-13-1 | 98.0% | |
ML241是强有力的和有选择性的蛋白酶抑制剂。ML241抑制P97 ATPase与IC | ||||
179833 | ML364 | 1991986-30-1 | 98.0% | |
ML364是具有潜在抗癌活性的小分子抑制剂的去泛素化酶USP2。 | ||||
179827 | 盐酸米托蒽醌 | 70476-82-3 | 98.0% | |
盐酸米托蒽醌是一种蒽醌抗生素,具有抗肿瘤活性的盐酸盐。米托 | ||||
179826 | ML311 | 315698-17-0 | 98.0% | |
ML311,也被称为EU-5346,是强有力的和有选择性的Mcl-1和Bim蛋白相互 | ||||
179810 | ML-18 | 1422269-30-4 | 98.0% | |
ML-18是蛙皮素受体亚型3(BRS-3)拮抗剂(IC50 = 4.8μm)。ML-18抑制肺 | ||||
1781501 | 1-甲基咪唑烷-2,4,5-三酮 | 3659-97-0 | 98.0% | |
1-甲基咪唑烷-2,4,5-三酮;1-MethyliMidazolidine-2,4,5-Trione |